Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
9
×
boston
boston blog main
boston top stories
life sciences
national blog main
national top stories
event
life science
national
clinical trials
deals
fda
roche
alexion pharmaceuticals
alnylam pharmaceuticals
avapritinib
blueprint medicines
boehringer ingelheim
cstone pharmaceuticals
dicerna pharamceuticals
eli lilly
european medicines agency
fisogatinib
flatiron health
genentech
hepatitis b
hepatitis b virus
hepatocellular carcinoma
hereditary transthyretin amyloidosis
investing
jeff albers
medullary thyroid cancer
non-small cell lung cancer
patisiran
pralsetinib
rna interference
san francisco blog main
san francisco top stories
selpercatinib
What
team
9
×
accelerating
attend
biopharma's
biopharma’s
boston
breakthroughs
digital
future
health
learn
life
medical
registering
sciences
tech
xcelerating
join
online
drug
medicines
roche
approval
bird
blueprint
cancer
candidate
caught
causing
currently
dicerna
disease
early
ends
eye
fda
gene
hepatitis
intended
marketing
Language
unset
Current search:
team
×
biotech
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
3 years ago
Join us this Wednesday for Xcelerating Life Sciences: Biopharma’s Future in Digital Health
@xconomy.com
3 years ago
Join Us Online May 13 for Xcelerating Life Sciences: Biopharma’s Future in Digital Health
@xconomy.com
3 years ago
Join Us Online May 13 for Xcelerating Life Sciences: Biopharma’s Future in Digital Health
@xconomy.com
3 years ago
Join Us Online May 13 for Xcelerating Life Sciences: Biopharma’s Future in Digital Health
@xconomy.com
3 years ago
Join Us Online May 13 for Xcelerating Life Sciences: Biopharma’s Future in Digital Health
@xconomy.com
3 years ago
Join Us Online May 13 for Xcelerating Life Sciences: Biopharma’s Future in Digital Health
@xconomy.com
3 years ago
Early Bird Sale Ends Today for Xcelerating Life Sciences Boston: Biopharma’s Future in Digital Health
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
